University of Colorado Cancer Center
Kirk Hansen is the John Stewart Professor of Peptide Chemistry at the University of Colorado Anschutz Medical Campus and also serves as a Professor at the University of Colorado Denver. With prior experience as CEO of Omix Technologies, Inc., Kirk Hansen has a strong background in leadership and innovation in the field of chemistry. Academic training includes a Bachelor of Science in Chemistry from Colorado State University and postdoctoral work at UCSF, following education at Caltech from 1996 to 2001.
This person is not in any teams